{"filing":{"accession_number":"0001753926-26-001479","cik":"0001494891","ticker":"SRTS","company_name":"Sensus Healthcare, Inc.","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"g085863_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1494891/000175392626001479/g085863_8k.htm"},"events":[{"id":27633,"run_id":25197,"accession_number":"0001753926-26-001479","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release discloses quarterly financial results including revenues of $2.3 million (down 68.5% YoY), net loss of $8.7 million per share, and adjusted EBITDA of negative $3 million. The filing includes consolidated statements of operations and balance sheet data, making this a standard quarterly earnings announcement material to investors assessing the company's financial performance.","company_name":"Sensus Healthcare, Inc.","ticker":"SRTS","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29224,"accession_number":"0001753926-26-001479","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release discloses quarterly financial results including revenues of $2.3 million (down 68.5% YoY), net loss of $8.7 million per share, and adjusted EBITDA of negative $3 million. The filing includes consolidated statements of operations and balance sheet data, making this a standard quarterly earnings announcement material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:04:58.482037+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29224,"accession_number":"0001753926-26-001479","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release discloses quarterly financial results including revenues of $2.3 million (down 68.5% YoY), net loss of $8.7 million per share, and adjusted EBITDA of negative $3 million. The filing includes consolidated statements of operations and balance sheet data, making this a standard quarterly earnings announcement material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:04:58.482037+00:00","company_name":"Sensus Healthcare, Inc.","ticker":"SRTS","filing_date":"2026-08-13"}]}